Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Next-ChemX Corporation (CHMX)
Las Vegas, NV, US
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation operates as a subsidiary of NEXT-ChemX Texas.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -99.78% | -99.89% | -99.98% | -99.15% | -99.15% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Software - Application: +13.0%—
-
EPS growth Software - Application: +28.6%+23.3% Q2'25: -32.2% (vs Q2'24)
-
FCF margin FCF growth · Software - Application: +45.3%—
-
EBIT margin Software - Application: +9.4%—
-
ROIC Software - Application: +7.5%— Q2'25: +160.3% (vs Q2'24)
-
Share dilution Software - Application: +0.0%+0.3% Q2'25: 0.0% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×-1.54× Q2'25: -2.11× (vs Q2'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | NEXT-ChemX Corporation. | Director | J-Other | D | PREFERRED STOCK SERIES A | 10,000 | 0.00 | 10.00 | 0 | D | ↗ |
| 2025-06-30 | JOHNSON JOHN MICHAEL | Director / Officer | J-Other | D | PREFERRED STOCK SERIES F | 10,000 | 0.00 | 10.00 | 0 | D | ↗ |
| 2024-09-23 | NEXT-ChemX Corporation. | Director | A-Award | A | PREFERRED STOCK SERIES F | 10,000 | 0.00 | 10.00 | 10,000 | D | ↗ |
| 2024-09-23 | JOHNSON JOHN MICHAEL | Director / Officer | A-Award | A | PREFERRED STOCK SERIES F | 10,000 | 0.00 | 10.00 | 10,000 | D | ↗ |
| 2024-09-05 | Sparkie Properties LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 15,866,096 | — | ↗ |
| 2024-05-29 | NEXT-ChemX Corporation. | Director | A-Award | A | PREFERRED STOCK SERIES A | 10,000 | 0.00 | 10.00 | 10,000 | D | ↗ |
| 2024-05-29 | JOHNSON JOHN MICHAEL | Director / Officer | A-Award | A | PREFERRED STOCK SERIES A | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-11-12 | JOHNSON JOHN MICHAEL | Director / Officer | M-Exempt | A | COMMON STOCK | 16,217 | 1.00 | 16.2K | 57,473 | D | ↗ |
| 2022-07-01 | Majendie Dominic John George Gordon | Officer | G-Gift | D | Common Stock | 18,036 | 0.00 | — | 160 | — | ↗ |
| 2022-06-17 | Majendie Dominic John George Gordon | Officer | M-Exempt | D | Convertible Promissory Note | 0 | 1.00 | — | 0 | — | ↗ |
| 2022-06-17 | JOHNSON JOHN MICHAEL | Director / Officer | M-Exempt | A | COMMON STOCK | 41,256 | 1.00 | 41.3K | 41,256 | D | ↗ |
| 2022-05-09 | JOHNSON JOHN MICHAEL | Director / Officer | A-Award | A | CONVERTIBLE PROMISSORY NOTE see note | 41,000 | 1.00 | 41.0K | 41,000 | — | ↗ |
| 2022-04-18 | Majendie Dominic John George Gordon | Officer | — | D | Convertible Promissory Note | 18,000 | 1.00 | 18.0K | 0 | — | ↗ |
| 2021-12-23 | WILCOXON BENTON H | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-23 | NEXT-ChemX Corp./TX | Officer / 10% Owner | — | D | Common Shares | 0 | 0.00 | — | 23,844,448 | — | ↗ |
| 2021-12-23 | KOCHERGINSKY NIKOLAI MEEROVICH | 10% Owner | — | I | COMMON STOCK | 0 | 0.00 | — | 4,998,989 | — | ↗ |
| 2021-12-23 | JOHNSON JOHN MICHAEL | Director / Officer | — | I | COMMON STOCK | 0 | 0.00 | — | 1,311,445 | — | ↗ |
| 2021-11-12 | JOHNSON JOHN MICHAEL | Director / Officer | C-Conversion | A | CONVERTIBLE PROMISSORY NOTE see note | 15,000 | 1.00 | 15.0K | 15,000 | — | ↗ |
| 2021-04-27 | JOHNSON JOHN MICHAEL | Director / Officer | J-Other | A | COMMON STOCK | 1,311,445 | 0.00 | — | 1,311,445 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
| Filing date | Form type | Filing |
|---|---|---|
| 2022-06-14 | DEF 14A | ↗ |
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dmitry Sindalovsky | Founder and Vice President Technology Coordination & Business Development | — | male |
| Dominic J. Majendie | Consultant | — | male |
| John Michael Johnson | Founder, Chief Financial Officer, President, Treasurer & Director | — | male |
| Nikolai Kocherginsky | Founder & Chief Scientist | — | — |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CHMX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
